Skip to main content
Back to European Investment Bank

European Investment Bank's Therapeutics Portfolio

Browse 10 Therapeutics companies funded by European Investment Bank. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
10
Total Funding in Therapeutics
$299.7M

Therapeutics Portfolio Companies (10)

Export
BiotechnologyGeneticsHealth CareTherapeutics

Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.

Basel, Switzerland
October 2026
$134.7M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Amsterdam, The Netherlands
June 2026
$45.4M
Undisclosed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

Lyon, France
November 2025
$10.6M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Copenhagen, Denmark
September 2025
$6.6M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Anocca is a clinical-stage biopharmaceutical company that develops T-cell receptors to treat infectious and autoimmune diseases.

Södertälje, Sweden
August 2025
$46.1M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

Bordeaux, France
May 2025
$34.0M
Debt Financing

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Medical DeviceNeuroscienceTherapeutics

INBRAIN Neuroelectronics is a BCI therapeutics company using graphene to build the least invasive and most intelligent neural platform

Barcelona, Spain
May 2025
$4.5M
Grant

Founder Contacts

41,000+ verified contacts

Health CareMedical DeviceTherapeutics

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

Eindhoven, The Netherlands
August 2023
$13.6M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.

Zwijnaarde, Belgium
June 2023
$1.7M
Grant

Founder Contacts

41,000+ verified contacts

Therapeutics

Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.

Brescia, Italy
September 2022
$2.5M
Grant

Founder Contacts

41,000+ verified contacts

Explore European Investment Bank's Full Portfolio

View all companies funded by European Investment Bank across every industry and funding stage.

View Full European Investment Bank Portfolio